Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: A systematic review and meta-analysis

详细信息    查看全文

• 作者：Daniel S. Epstein^a ; ^b ; Biswadev Mitra^a ; ^b ; ^{biswadev.mitra@monash.edu" class="auth_mail} ; Gerard O&rsquo ; Reilly^a ; ^b ; Jeffrey V. Rosenfeld^b ; ^c ; ^d ; Peter A. Cameron^a ; ^b ; ^e
• 关键词：Wound and injuries ; Coagulopathy ; Blood coagulation ; Traumatic brain injury ; Craniocerebral trauma ; Brain injuries ; Isolated head trauma
• 刊名：Injury
• 出版年：May, 2014
• 年：2014
• 卷：45
• 期：5
• 页码：819-824
• 全文大小：291 K

文摘

Background and objectives

Acute traumatic coagulopathy (ATC) has been reported in the setting of isolated traumatic brain injury (iTBI) and associated with high mortality and poor outcomes. The aim of this systematic review was to examine the incidence and outcome of patients with ATC in the setting of iTBI.

Methods

We conducted a search of the MEDLINE database and Cochrane library, focused on subject headings and keywords involving coagulopathy and TBI. Design and results of each study were described. Studies were assessed for heterogeneity and the pooled incidence of ATC in the setting of iTBI determined. Reported outcomes were described.

Results

There were 22 studies selected for analysis. A statistically significant heterogeneity among the studies was observed (p < 0.01). Using the random effects model the pooled proportion of patients with ATC in the setting of iTBI was 35.2% (95% CI: 29.0-41.4). Mortality of patients with ATC and iTBI ranged between 17% and 86%. Higher blood transfusion rates, longer hospital stays, longer ICU stays, decreased ventilator free days, higher rates of single and multiple organ failure and higher incidence of delayed injury and disability at discharge were reported among patients with ATC.

Conclusions

ATC is commonly associated with iTBI and almost uniformly associated with worse outcomes. Any disorder of coagulation above the normal range appears to be associated with worse outcomes and therefore a clinically important target for management. Earlier identification of patients with ATC and iTBI, for recruitment into prospective trials, presents avenues for further research.